Author
Márcio Jansen de Oliveira Figueiredo
Bio: Márcio Jansen de Oliveira Figueiredo is an academic researcher from State University of Campinas. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 12, co-authored 27 publications receiving 606 citations.
Papers
More filters
••
Aalborg University1, University of Birmingham2, University of Barcelona3, Karolinska Institutet4, University of Modena and Reggio Emilia5, Athens State University6, University of Southern Denmark7, University of Murcia8, State University of Campinas9, University of Colorado Denver10, Taipei Veterans General Hospital11, University College London12
TL;DR: A Task Force was convened with the remit to comprehensively review the available evidence to publish a joint consensus document on hypertension and cardiac arrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice.
Abstract: Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease, stroke, peripheral artery disease and chronic renal insufficiency. Hypertensive heart disease can manifest as many cardiac arrhythmias, most commonly being atrial fibrillation (AF). Both supraventricular and ventricular arrhythmias may occur in hypertensive patients, especially in those with left ventricular hypertrophy (LVH) or HF. Also, some of the antihypertensive drugs commonly used to reduce blood pressure, such as thiazide diuretics, may result in electrolyte abnormalities (e.g. hypokalaemia, hypomagnesemia), further contributing to arrhythmias, whereas effective control of blood pressure may prevent the development of the arrhythmias such as AF. In recognizing this close relationship between hypertension and arrhythmias, the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Council on Hypertension convened a Task Force, with representation from the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE), with the remit to comprehensively review the available evidence to publish a joint consensus document on hypertension and cardiac arrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and the patient in light of all of the circumstances presented by that patient.
138 citations
••
Eskişehir Osmangazi University1, University of Modena and Reggio Emilia2, Maastricht University Medical Centre3, University Medical Center Groningen4, Technische Universität München5, University of Birmingham6, Aalborg University7, Australian Catholic University8, Services Hospital9, Paracelsus Private Medical University of Salzburg10, Royal Adelaide Hospital11, Hacettepe University12, Cleveland Clinic13, St George's, University of London14, Oslo University Hospital15, Taipei Veterans General Hospital16, State University of Campinas17, Waikato Hospital18, University of Washington19, University Hospital of Lausanne20
TL;DR: By implementing AF risk reduction strategies aiming at risk factors such as obesity, hypertension, diabetes, and obstructive sleep apnoea (OSA), which are interrelated, this work impact upon the escalating escalating risk of developing AF.
Abstract: ACEI,
: angiotensin converting enzyme inhibitors
AF,
: atrial fibrillation
ARB,
: angiotensin receptor blockers
AVNRT,
: atrioventricular nodal re-entry tachycardia
BMI,
: body mass index
CHADS2,
: cardiac failure, hypertension, age, diabetes, stroke (doubled)
CHA2DS2-VASc,
: congestive heart failure or left ventricular dysfunction, hypertension, age ≥75 (doubled), diabetes, stroke/transient ischaemic attack (doubled)-vascular disease, age 65–74, sex category (female)
CI,
: confidence interval
FU,
: follow-up
HR,
: hazard ratio
HDL,
: high-density lipoprotein cholesterol
ICD,
: implantable cardioverter defibrillators
LA,
: left atrium
LDL,
: low-density lipoprotein cholesterol
LV,
: left ventricle
NOAC,
: non-VKA oral anticoagulant
OAC,
: oral anticoagulation
OR,
: odds ratio
OSA,
: obstructive sleep apnoea
n 3-PUFA,
: ω-3 polyunsaturated fatty acids
RAAS,
: renin–angiotensin–aldosterone system
RR,
: relative risk
SBP,
: systolic blood pressure
SAMe-TT2R2,
: sex (female), age (<60 years), medical history, treatment (interacting drugs, eg amiodarone for rhythm control), tobacco use (within 2 years) (doubled), Race (non-Caucasian) (doubled)
SVT,
: supraventricular tachyarrhythmia
VKA,
: vitamin K antagonist
Atrial fibrillation (AF) is an important and highly prevalent arrhythmia, which is associated with significantly increased morbidity and mortality, including a four- to five-fold increased risk for stroke,1,2 a two-fold increased risk for dementia,3,4 a three-fold risk for heart failure,2 a two-fold increased risk for myocardial infarction,5,6 and a 40–90% increased risk for overall mortality2,7 The constantly increasing number of AF patients and recognition of increased morbidity, mortality, impaired quality of life, safety issues, and side effects of rhythm control strategies with antiarrhythmic drugs, and high healthcare costs associated with AF have spurred numerous investigations to develop more effective treatments for AF and its complications8 Although AF treatment has been studied extensively, AF prevention has received relatively little attention, while it has paramount importance in the prevention of morbidity and mortality, and complications associated with arrhythmia and its treatment Current evidence shows a clear association between the presence of modifiable risk factors and the risk of developing AF
By implementing AF risk reduction strategies aiming at risk factors such as obesity, hypertension, diabetes, and obstructive sleep apnoea (OSA), which are interrelated, we impact upon the escalating …
105 citations
••
University of Oxford1, Wellcome Trust Centre for Human Genetics2, University of Buckingham3, Imperial College London4, University of Aberdeen5, University of Cambridge6, Universidade Federal de Minas Gerais7, Hungarian Academy of Sciences8, University of Dundee9, State University of Campinas10, University of Michigan11, Semmelweis University12, Tufts Medical Center13
TL;DR: It is observed that mice with chronic AMPK activation, resulting from mutation of the AMPK γ2 subunit, exhibit ghrelin signaling-dependent hyperphagia, obesity, and impaired pancreatic islet insulin secretion.
86 citations
••
63 citations
••
Aarhus University Hospital1, Taipei Veterans General Hospital2, State University of Campinas3, Leipzig University4, Argerich Hospital5, University of Wisconsin-Madison6, Virginia Commonwealth University7, University of São Paulo8, Toho University9, Case Western Reserve University10, University of British Columbia11, University of Rochester Medical Center12, Semmelweis University13, University of Melbourne14, Aalborg University15, University of Liverpool16, University Health System17, Institute for Social Security and Services for State Workers18, Brigham and Women's Hospital19, University of Copenhagen20, University of California, Los Angeles21, University of Amsterdam22, Intermountain Medical Center23, Beth Israel Deaconess Medical Center24, Ludwig Maximilian University of Munich25, Libin Cardiovascular Institute of Alberta26, University of California, San Francisco27, University of Ulsan28, Roy J. and Lucille A. Carver College of Medicine29, Sree Chitra Thirunal Institute for Medical Sciences and Technology30, Anschutz Medical Campus31, Ruhr University Bochum32, Waikato Hospital33, McGill University34, University of Rennes35
TL;DR: This expert consensus statement task force was set down to raise awareness of using the right risk assessment tool for a given outcome in a given population, and to provide physicians with practical proposals that may lead to rational and evidence-based risk assessment and improvement of patient care in this regard.
62 citations
Cited by
More filters
••
5,737 citations
••
Leipzig University1, University of Belgrade2, Leiden University3, Uppsala University4, University of Modena and Reggio Emilia5, University of Barcelona6, Carol Davila University of Medicine and Pharmacy7, National and Kapodistrian University of Athens8, François Rabelais University9, Royal Melbourne Hospital10, University of Melbourne11, University of Lisbon12, University of Birmingham13, University of Groningen14, University Medical Center Groningen15, University of Central Lancashire16
TL;DR: The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only and no commercial use is authorized.
Abstract: Supplementary Table 9, column 'Edoxaban', row 'eGFR category', '95 mL/min' (page 15). The cell should be coloured green instead of yellow. It should also read "60 mg"instead of "60 mg (use with caution in 'supranormal' renal function)."In the above-indicated cell, a footnote has also been added to state: "Edoxaban should be used in patients with high creatinine clearance only after a careful evaluation of the individual thromboembolic and bleeding risk."Supplementary Table 9, column 'Edoxaban', row 'Dose reduction in selected patients' (page 16). The cell should read "Edoxaban 60 mg reduced to 30 mg once daily if any of the following: creatinine clearance 15-50 mL/min, body weight <60 kg, concomitant use of dronedarone, erythromycin, ciclosporine or ketokonazole"instead of "Edoxaban 60 mg reduced to 30 mg once daily, and edoxaban 30 mg reduced to 15mg once daily, if any of the following: creatinine clearance of 30-50 mL/min, body weight <60 kg, concomitant us of verapamil or quinidine or dronedarone."
4,285 citations
••
TL;DR: De Backer et al. as mentioned in this paper developed the ESC Guidelines for the ESC Review Co-ordinator, which are used for the evaluation of the ESC review process and the review process.
Abstract: Document reviewers: Guy De Backer (ESC Review Co-ordinator) (Belgium), Anthony M. Heagerty (ESH Review Co-ordinator) (UK), Stefan Agewall (Norway), Murielle Bochud (Switzerland), Claudio Borghi (Italy), Pierre Boutouyrie (France), Jana Brguljan (Slovenia), Hector Bueno (Spain), Enrico G. Caiani (Italy), Bo Carlberg (Sweden), Neil Chapman (UK), Renata Cifkova (Czech Republic), John G. F. Cleland (UK), Jean-Philippe Collet (France), Ioan Mircea Coman (Romania), Peter W. de Leeuw (The Netherlands), Victoria Delgado (The Netherlands), Paul Dendale (Belgium), Hans-Christoph Diener (Germany), Maria Dorobantu (Romania), Robert Fagard (Belgium), Csaba Farsang (Hungary), Marc Ferrini (France), Ian M. Graham (Ireland), Guido Grassi (Italy), Hermann Haller (Germany), F. D. Richard Hobbs (UK), Bojan Jelakovic (Croatia), Catriona Jennings (UK), Hugo A. Katus (Germany), Abraham A. Kroon (The Netherlands), Christophe Leclercq (France), Dragan Lovic (Serbia), Empar Lurbe (Spain), Athanasios J. Manolis (Greece), Theresa A. McDonagh (UK), Franz Messerli (Switzerland), Maria Lorenza Muiesan (Italy), Uwe Nixdorff (Germany), Michael Hecht Olsen (Denmark), Gianfranco Parati (Italy), Joep Perk (Sweden), Massimo Francesco Piepoli (Italy), Jorge Polonia (Portugal), Piotr Ponikowski (Poland), Dimitrios J. Richter (Greece), Stefano F. Rimoldi (Switzerland), Marco Roffi (Switzerland), Naveed Sattar (UK), Petar M. Seferovic (Serbia), Iain A. Simpson (UK), Miguel Sousa-Uva (Portugal), Alice V. Stanton (Ireland), Philippe van de Borne (Belgium), Panos Vardas (Greece), Massimo Volpe (Italy), Sven Wassmann (Germany), Stephan Windecker (Switzerland), Jose Luis Zamorano (Spain).The disclosure forms of all experts involved in the development of these Guidelines are available on the ESC website www.escardio.org/guidelines.
1,781 citations
••
1,650 citations
••
Johns Hopkins University1, Leipzig University2, Korea University3, Yale University4, West Virginia University5, University of Barcelona6, St George's, University of London7, Indiana University8, National Yang-Ming University9, Cleveland Clinic10, Aarhus University11, University at Buffalo12, Imperial College London13, Primary Children's Hospital14, Erasmus University Rotterdam15, Yeshiva University16, Ghent University17, Baylor University18, Virginia Commonwealth University19, Harvard University20, Federal University of São Paulo21, University of California, San Francisco22, Beaumont Hospital23, Boston University24, University of Oklahoma25, Carlos III Health Institute26, University of Michigan27, University of Melbourne28, Saint Louis University29, Université de Montréal30, University of Pennsylvania31, McGill University32, Mayo Clinic33, Lahey Hospital & Medical Center34, Royal Adelaide Hospital35, University of Milan36, University of Toronto37, Loyola University Chicago38, Jikei University School of Medicine39
TL;DR: This 2017 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF and to report the findings of a writing group, convened by these five international societies.
1,626 citations